ArticleOncotarget2017

Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes.

Emily Kolyvas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.